Literature DB >> 10512354

No effect of insulin on glucose blood-brain barrier transport and cerebral metabolism in humans.

S G Hasselbalch1, G M Knudsen, C Videbaek, L H Pinborg, J F Schmidt, S Holm, O B Paulson.   

Abstract

The effect of hyperinsulinemia on glucose blood-brain barrier (BBB) transport and cerebral metabolism (CMRglc) was studied using the intravenous double-indicator method and positron emission tomography using [18F]fluorodeoxyglucose as tracer (PET-FDG). Sixteen normal healthy control subjects (25 +/- 4 years old) were studied twice during a euglycemic and a euglycemic-hyperinsulinemic condition. Our hypothesis was that high physiologic levels of insulin did not affect the BBB transport or net metabolism of glucose. During insulin infusion, arterial plasma insulin levels increased from 48.5 to 499.4 pmol/l. The permeability-surface area products for glucose and FDG BBB transport obtained with the double-indicator method remained constant during hyperinsulinemia. Similarly using PET-FDG, no changes were observed in the unidirectional clearance of FDG from blood to brain. k2* (FDG transport from brain to blood) increased significantly by 15 and 18% (gray and white matter, respectively), and k4* (dephosphorylation of FDG) increased by 18%. The increase in k2* may be caused by insulin inducing a decrease in the available FDG brain pool. The increase in k4* may be related to an increased loss of labeled products during insulin fusion. Irrespective of these changes, CMRglc remained unchanged in all brain regions. We conclude that hyperinsulinemia within the normal physiologic range does not affect BBB glucose transport or net cerebral glucose metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10512354     DOI: 10.2337/diabetes.48.10.1915

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  47 in total

Review 1.  The role of insulin resistance in the pathogenesis of Alzheimer's disease: implications for treatment.

Authors:  G Stennis Watson; Suzanne Craft
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Hippocampal memory processes are modulated by insulin and high-fat-induced insulin resistance.

Authors:  Ewan C McNay; Cecilia T Ong; Rory J McCrimmon; James Cresswell; Jonathan S Bogan; Robert S Sherwin
Journal:  Neurobiol Learn Mem       Date:  2010-02-20       Impact factor: 2.877

3.  AKT2 maintains brain endothelial claudin-5 expression and selective activation of IR/AKT2/FOXO1-signaling reverses barrier dysfunction.

Authors:  Richard S Beard; Brian A Hoettels; Jamie E Meegan; Travis S Wertz; Byeong J Cha; Xiaoyuan Yang; Julia T Oxford; Mack H Wu; Sarah Y Yuan
Journal:  J Cereb Blood Flow Metab       Date:  2018-12-21       Impact factor: 6.200

4.  EANM procedure guidelines for PET brain imaging using [18F]FDG, version 2.

Authors:  Andrea Varrone; Susanne Asenbaum; Thierry Vander Borght; Jan Booij; Flavio Nobili; Kjell Någren; Jacques Darcourt; Ozlem L Kapucu; Klaus Tatsch; Peter Bartenstein; Koen Van Laere
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-12       Impact factor: 9.236

5.  The cerebrocortical response to hyperinsulinemia is reduced in overweight humans: a magnetoencephalographic study.

Authors:  Otto Tschritter; Hubert Preissl; Anita M Hennige; Michael Stumvoll; Katarina Porubska; Rebekka Frost; Hannah Marx; Benjamin Klösel; Werner Lutzenberger; Niels Birbaumer; Hans-Ulrich Häring; Andreas Fritsche
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-28       Impact factor: 11.205

6.  Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.

Authors:  A Michael Peters; Georgia Keramida; Deborah Pencharz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-07-17       Impact factor: 9.236

Review 7.  Emerging links between type 2 diabetes and Alzheimer's disease.

Authors:  Gumpeny R Sridhar; Gumpeny Lakshmi; Gumpeny Nagamani
Journal:  World J Diabetes       Date:  2015-06-10

8.  Glycemic control and chronic dosing of rhesus monkeys with a fusion protein of iduronidase and a monoclonal antibody against the human insulin receptor.

Authors:  Ruben J Boado; Eric Ka-Wai Hui; Jeff Zhiqiang Lu; William M Pardridge
Journal:  Drug Metab Dispos       Date:  2012-07-20       Impact factor: 3.922

9.  Dexamethasone-induced insulin resistance: kinetic modeling using novel PET radiopharmaceutical 6-deoxy-6-[(18)F]fluoro-D-glucose.

Authors:  Kuan-Hao Su; Visvanathan Chandramouli; Faramarz Ismail-Beigi; Raymond F Muzic
Journal:  Mol Imaging Biol       Date:  2014-10       Impact factor: 3.488

10.  Stress and eating behavior.

Authors:  Achim Peters; Dirk Langemann
Journal:  F1000 Biol Rep       Date:  2010-02-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.